Tag: dna polymerase
Establishment and characterization of a fucosylated α-fetoprotein-specific monoclonal antibody: a potential application for clinical research
The Lens culinaris agglutinin (LCA)-reactive fraction of α-fetoprotein (AFP-L3) is a well-known cancer biomarker for hepatocellular carcinoma (HCC) with very high specificity. Because LCA recognizes only bi-antennary N-glycans with a core fucose, some of fucosylated AFP in HCC patients may not be detected. Then glycan antibodies, which recognize both specific glycan and protein, are desired…
Read More
GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions
Hepatocellular carcinoma is essentially the most frequent major liver most cancers. Macroautophagy/autophagy inhibitors have been extensively studied in most cancers however, thus far, none has reached efficacy in medical trials. On this research, we demonstrated that GNS561, a brand new autophagy inhibitor, whose anticancer exercise was beforehand linked to lysosomal cell loss of life, displayed…
Read More